Ariad Pharma (ARIA) Posts Wider than Expected Q2 Loss of 31c/Share

Ariad Pharma (NASDAQ: ARIA) reported Q2 EPS of ($0.31), $0.04 worse than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Ariad Pharma (ARIA) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• InspireMD (NSPR) Tops Q2 EPS by 1c
• Cloudastructure reports 164% subscription revenue growth in Q2 2026